Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Antiepileptic Drugs: Calcium Channel Blockers01:17

Antiepileptic Drugs: Calcium Channel Blockers

770
Calcium channel blockers, a class of antiepileptic drugs, regulate the flow of calcium ions within neurons.
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
770
Fractures: Bone Repair01:27

Fractures: Bone Repair

4.0K
Treatment for a fracture is based on the type of break, the bone affected, and the patient's age.
Minor fractures with no bone displacement are treated by immobilizing the fractured bone using a cast or splint. However, in the case of fractures with displaced bones, the broken bones are repositioned before immobilization to ensure successful healing without deformation and loss of function. The realignment of fractured bone ends is performed through a process called reduction. If the...
4.0K
Antiepileptic Drugs: Glutamate Antagonists01:14

Antiepileptic Drugs: Glutamate Antagonists

596
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
596
Antiepileptic Drugs: Potassium Channel Activators01:20

Antiepileptic Drugs: Potassium Channel Activators

368
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
368
Antiepileptic Drugs: Sodium Channel Blockers01:08

Antiepileptic Drugs: Sodium Channel Blockers

1.1K
Antiepileptic drugs are specialized medications that prevent seizures in individuals diagnosed with epilepsy. These drugs primarily function by blocking the movement of sodium ions through channels in the neuronal membrane, inhibiting the repetitive firing of action potentials often associated with seizures.
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
1.1K
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants01:18

Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants

1.5K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
1.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Incidence of vertebral fracture in a cohort of Australian women: data from the Geelong Osteoporosis Study.

Archives of osteoporosis·2026
Same author

Relative contributions of modifiable risk factors to injurious fall prediction in older adults: A predictive modelling study.

Archives of gerontology and geriatrics·2026
Same author

Key determinants for lowering the risk of joint replacement in weight-bearing joints: a population-based cohort study.

Arthroplasty (London, England)·2026
Same author

Applied comparison of stepwise Cox and Cox-LASSO regression in selecting determinants of joint replacement: insights from the Geelong Osteoporosis Study.

BMC musculoskeletal disorders·2026
Same author

Anti-inflammatory diet and mental health outcomes in an aging population: evidence from a preventive population-based target trial emulation.

GeroScience·2026
Same author

Associations of gait speed, grip strength, depressive symptoms, and their combinations with fracture risk in older adults.

GeroScience·2026

Related Experiment Video

Updated: Oct 22, 2025

Assessment of Bone Fracture Healing Using Micro-Computed Tomography
12:04

Assessment of Bone Fracture Healing Using Micro-Computed Tomography

Published on: December 9, 2022

2.1K

Anticonvulsant use and fracture: a case-control study.

Vinoomika Chandrasekaran1, Amanda L Stuart1, Julie A Pasco1,2,3,4

  • 1Deakin University, IMPACT, The Institute for Mental and Physical Health and Clinical Translation, Geelong, Australia.

Journal of Musculoskeletal & Neuronal Interactions
|September 1, 2021
PubMed
Summary

Anticonvulsant use significantly increases fracture risk in both men and women. This study found a higher risk of bone fractures associated with anticonvulsant medications.

Keywords:
AnticonvulsantCase-Control StudyFractureOsteoporosis

More Related Videos

Fracture Apparatus Design and Protocol Optimization for Closed-stabilized Fractures in Rodents
06:59

Fracture Apparatus Design and Protocol Optimization for Closed-stabilized Fractures in Rodents

Published on: August 14, 2018

13.7K
Minimally Invasive Treatment for Thoracolumbar Burst Fracture Using Sagittal Alignment Screws and A Trauma Reduction Device
04:19

Minimally Invasive Treatment for Thoracolumbar Burst Fracture Using Sagittal Alignment Screws and A Trauma Reduction Device

Published on: November 8, 2024

674

Related Experiment Videos

Last Updated: Oct 22, 2025

Assessment of Bone Fracture Healing Using Micro-Computed Tomography
12:04

Assessment of Bone Fracture Healing Using Micro-Computed Tomography

Published on: December 9, 2022

2.1K
Fracture Apparatus Design and Protocol Optimization for Closed-stabilized Fractures in Rodents
06:59

Fracture Apparatus Design and Protocol Optimization for Closed-stabilized Fractures in Rodents

Published on: August 14, 2018

13.7K
Minimally Invasive Treatment for Thoracolumbar Burst Fracture Using Sagittal Alignment Screws and A Trauma Reduction Device
04:19

Minimally Invasive Treatment for Thoracolumbar Burst Fracture Using Sagittal Alignment Screws and A Trauma Reduction Device

Published on: November 8, 2024

674

Area of Science:

  • Epidemiology
  • Pharmacology
  • Orthopedics

Background:

  • Anticonvulsant medications are widely prescribed for various neurological conditions.
  • Previous studies have suggested a potential link between anticonvulsant use and bone health, but evidence remains inconsistent.
  • Understanding the fracture risk associated with anticonvulsant use is crucial for patient safety and clinical management.

Purpose of the Study:

  • To investigate the association between anticonvulsant drug use and the risk of fractures in a population-based sample.
  • To determine if this association differs between men and women.
  • To identify potential confounding factors influencing the relationship between anticonvulsant use and fracture risk.

Main Methods:

  • A population-based case-control study was conducted.
  • Cases (n=1,458) had radiologically confirmed incident fractures, while controls (n=1,796) did not.
  • Data on lifestyle, medication use, and medical history were self-reported, and binary logistic regression was used for analysis after adjusting for confounders.

Main Results:

  • Anticonvulsant use was associated with a 2.8-fold higher fracture risk in men and a 1.8-fold higher fracture risk in women, even after adjusting for multiple confounders.
  • Significant differences in demographic and lifestyle factors were observed between fracture cases and controls in both sexes.
  • The association between anticonvulsant use and increased fracture risk persisted after accounting for various demographic, lifestyle, medical, and medication-related factors.

Conclusions:

  • Anticonvulsant use is an independent risk factor for fractures in both men and women.
  • Further research is needed to elucidate the underlying mechanisms contributing to this increased fracture risk.
  • Regular bone health monitoring is recommended for individuals using anticonvulsants, particularly those with additional risk factors.